Trade Kintara Therapeutics, Inc. - KTRA CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | N/A |
| Open | 0.38 |
| 1-Year Change | -91.22% |
| Day's Range | 0.38 - 0.45 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Nov 29, 2023 | 0.39 | 0.01 | 2.63% | 0.38 | 0.46 | 0.38 |
| Nov 10, 2023 | 0.38 | 0.00 | 0.00% | 0.38 | 0.65 | 0.38 |
| Nov 9, 2023 | 0.38 | -0.02 | -5.00% | 0.40 | 0.40 | 0.37 |
| Nov 8, 2023 | 0.39 | -0.02 | -4.88% | 0.41 | 0.41 | 0.39 |
| Nov 7, 2023 | 0.41 | -0.01 | -2.38% | 0.42 | 0.42 | 0.38 |
| Nov 6, 2023 | 0.40 | -0.03 | -6.98% | 0.43 | 0.43 | 0.38 |
| Nov 3, 2023 | 0.41 | 0.00 | 0.00% | 0.41 | 0.46 | 0.40 |
| Nov 2, 2023 | 0.38 | -0.10 | -20.83% | 0.48 | 0.48 | 0.38 |
| Nov 1, 2023 | 0.48 | -0.22 | -31.43% | 0.70 | 0.70 | 0.46 |
| Oct 31, 2023 | 0.73 | -0.22 | -23.16% | 0.95 | 1.08 | 0.71 |
| Oct 30, 2023 | 3.72 | -0.04 | -1.06% | 3.76 | 3.88 | 3.62 |
| Oct 27, 2023 | 4.11 | 0.14 | 3.53% | 3.97 | 4.32 | 3.97 |
| Oct 26, 2023 | 4.08 | -0.10 | -2.39% | 4.18 | 4.34 | 4.08 |
| Oct 25, 2023 | 3.87 | -0.31 | -7.42% | 4.18 | 4.18 | 3.74 |
| Oct 24, 2023 | 4.10 | -0.18 | -4.21% | 4.28 | 4.28 | 4.08 |
| Oct 23, 2023 | 4.17 | 0.22 | 5.57% | 3.95 | 4.32 | 3.74 |
| Oct 20, 2023 | 3.97 | 0.00 | 0.00% | 3.97 | 4.30 | 3.97 |
| Oct 19, 2023 | 4.26 | 0.08 | 1.91% | 4.18 | 4.47 | 4.17 |
| Oct 18, 2023 | 4.04 | 0.36 | 9.78% | 3.68 | 4.07 | 3.68 |
| Oct 17, 2023 | 3.69 | 0.07 | 1.93% | 3.62 | 3.70 | 3.60 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Kintara Therapeutics, Inc. Company profile
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma; and REM-001, a photodynamic therapy for the treatment of cutaneous metastatic breast cancer. The company has a strategic collaboration with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. to manufacture and sell VAL-083 in China. The company was formerly known as DelMar Pharmaceuticals, Inc. and changed its name to Kintara Therapeutics, Inc. in August 2020. Kintara Therapeutics, Inc. was incorporated in 2009 and is headquartered in San Diego, California.| Industry: | Bio Therapeutic Drugs |
9920 Pacific Heights Blvd, Suite 150
Suite 200
92121
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024
US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024
Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024
US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024
Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024
US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024
How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com